MICB Gene Expression on Peripheral Blood Mononuclear Cells and Susceptibility to Multiple Sclerosis in North of Iran
-
Saeid Abediankenari
,
Yousef Yousefzadeh
,
Mohammad Majidi
,
Maryam Ghasemi
,
Mohammad Mahdi Nasehi
,
Javad Ghaffari
,
Reza Habibi Saravi
,
Mahmoud Abedini
,
Mitra Elyasi
Abstract
Multiple sclerosis (MS) is an autoimmune multifactorial degenerative disease with detrimental affliction on central nervous system. MHC class I chain- related geneA,B(MICA and MICB) are nonclassical human leukocyte antigens that can affect on some diseases and also on transplantation.
The purpose of this study was to evaluate the MICA and MICB MRNA expression in multiple sclerosis patients. In this study, we evaluated MICA and MICB MRNA expression in the peripheral blood mononuclear cells by reverse transcryptase-polymerase chain reaction(RT-PCR) in MS patients and normal controls.
The results of this study showed that 32.6% of patients with progressive clinical outcome over expressed MICB genes in comparison with controls ( p=0.002).
It is concluded that the high expression of MICB gene in MS patients is an important criterion of MS disease that it may be due to the interaction between MICB and its receptor on CD8+T or NK cells.
Rizvi S. Multiple sclerosis: current and future treatment options. Endocr Metab Immune Disord Drug Targets 2007; 7(4):292-9.
2. Boĭko AN, Favorova OO. Multiple sclerosis: molecular and cellular mechanisms. Mol Biol (Mosk) 1995;29(4):727-49.
3. Mechelli R, Annibali V, Ristori G, Vittori D, Coarelli G, Salvetti M. Multiple sclerosis etiology: beyond genes and environment. Expert Rev Clin Immunol 2010; 6(3):481-90.
4. Ramagopalan SV, Ebers GC. Multiple sclerosis: major histocompatibility complexity and antigen presentation. Genome Med 2009; 1(11):105.
5. Yasuoka H, Okazaki Y, Kawakami Y, Hirakata M, Inoko H, Ikeda Y, et al. Autoreactive CD8+ cytotoxic T lymphocytes to major histocompatibility complex class I chain-related gene A in patients with Behçet's disease. Arthritis Rheum 2004; 50(11):3658-62.
6. Shojima J, Tanaka G, Keicho N, Tamiya G, Ando S, Oka A, et al. Identification of MICA as a susceptibility gene for pulmonary Mycobacterium avium complex infection. J Infect Dis 2009; 199(11):1707-15.
7. Kohga K, Takehara T, Tatsumi T, Ishida H, Miyagi T, Hosui A, et al. Sorafenib inhibits the shedding of major histocompatibility complex class I-related chain A on hepatocellular carcinoma cells by down-regulating a disintegrin and metalloproteinase 9. Hepatology 2010;51(4):1264-73.
8. Groh V, Sleinle A, Bauer S, Spies T. Recognition of stress induced MHC molecules by intestinal epithelial γ§ T cells .Science 1998; 279(5357):1737-40.
9. Bauer S, Groh V, Wu J, Steinle A, Philips JH, Lanier LL, et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999;285(5428):727-9.
10. Pay S, Simşek I, Erdem H, Dinç A. Immunopathogenesis of Behçet's disease with special emphasize on the possible role of antigen presenting cells. Rheumatol Int 2007; 27(5):417-24.
11. Fuertes MB, Girart MV, Molinero LL, Domaica CI, Rossi LE, Barrio MM, et al. Intracellular retention of the NKG2D ligand MHC class I chain-related gene A in human melanomas confers immune privilege and prevents NK cell-mediated cytotoxicity. J Immunol 2008;180(7):4606-14.
12. Beetz S, Marischen L, Kabelitz D, Wesch D. Human gamma delta T cells: candidates for the development of immunotherapeutic strategies. Immunol Res 2007;37(2):97-111.
13. Groh V, Bruhl A, El-Gabalawi H, Nelson JL, Spies T.Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rhomatoid arthritis. Proc Natl Acad Sci USA 2003; 100(16):9452-7.
14. Ogasawara K, Hamerman JA, Ehrlich LR, Bour-Jordan H, Sanlamaria P, Bluestone JA, et al. NKG2D blockade prevents autoimmune diabetes in NOD mice. Immunity 2004; 20(6):757-67.
15. Hue S, Mention JJ, Monteiro RC, Zhang S, Cellier C, Schmitz J, et al. A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity 2004; 21(3):367-77.
16. Bauer S, Groh V, Wu J, Steinle A, Philip JH, Lanier LL,et al. Activation of NK cells and T cells by NKG2D, areceptor for stress-inducible in MICA. Science 1999;285(5428):727-9.
17. Groh V, Rhinehart R, Secrist H, Bauer S, Grabstein KH, Spies T. Broad tumor-associated expression and recognition by tumor-derived γ§T cells of MICA and MICB. Proc Natl Acad Sci USA 1999; 96(12):6879-84.
18. Fernandez-Morera JL, Rodriguez-Rodero S, Lahoz C, Tunon A, Astudillo A, Garcia-Suarez O, et al. Soluble MHC class I chain-related protein B serum levels correlate with disease activity in relapsing-remitting multiple sclerosis. Hum immunol 2005; 69:235-40.
19. Jinushi M, Takehara T, Tatsumi T, Kanto T, Groh V, spies T, et al. Expression and role of MICA and MICB in human hepatocellular carcinoma and their regulation by retinoic acid. Int J Cancer 2003; 104(3):354-61.
| Files | ||
| Issue | Vol 10, No 4 (2011) | |
| Section | Articles | |
| Keywords | ||
| MICA MICB Multiple sclerosis | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
